The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing: Regulated intramembrane proteolysis and APP processing
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
After initial BACE1 cleavage, the resulting C-terminal, membrane-bound protein fragments of several membrane proteins, including APP and SEZ6L, are further processed within their transmembrane domains by γ-secretase, in a process referred to as regulated intramembrane proteolysis.
“After initial BACE1 cleavage, the resulting C-terminal, membrane-bound protein fragments of several membrane proteins, including APP and SEZ6L [17], are further processed within their transmembrane domains by γ-secretase, in a process referred to as regulated intramembrane proteolysis [41]”
From Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons (2016) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Self-citationVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
Kuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621
Self-citationKuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532
Shen, J., & Kelleher, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608332104 · Cited by 485
Savonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K.-A., Price, D. L., & Wong, P. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710373105 · Cited by 290
The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate
von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 258
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1334-10.2010 · Cited by 162
Kojro, E., Postina, R., Buro, C., Meiringer, C., Gehrig‐Burger, K., & Fahrenholz, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-4812fje · Cited by 118
Flagged first, then by citations
Research works printed but not linked: 206
- Ahn, 2010, Activation and intrinsic γ-secretase activity of presenilin 1, Proc. Natl Acad. Sci. USA, 50, 21435, 10.1073/pnas.1013246107 · DOI
- Amour, 1998, TNF-α converting enzyme (TACE) is inhibited by TIMP-3, FEBS Lett., 435, 39, 10.1016/S0014-5793(98)01031-X · DOI
- Amour, 2000, The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3, FEBS Lett., 473, 275, 10.1016/S0014-5793(00)01528-3 · DOI
- Baumeister, 1997, Human presenilin-1, but not familial Alzheimer’s disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing, Genes Funct., 1, 149, 10.1046/j.1365-4624.1997.00012.x · DOI
- Bennett, 2000, A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer’s β-secretase, J. Biol. Chem., 275, 37712, 10.1074/jbc.M005339200 · DOI
- Bozkulak, 2009, Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling, Mol. Cell. Biol., 29, 5679, 10.1128/MCB.00406-09 · DOI
- Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
- Buxbaum, 1998, Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem., 273, 27765, 10.1074/jbc.273.43.27765 · DOI
- Caescu, 2009, Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10, Biochem. J., 424, 79, 10.1042/BJ20090549 · DOI
- Cao, 2001, A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, 293, 115, 10.1126/science.1058783 · DOI · Paper page
- Cao, 2004, Dissection of amyloid-β precursor protein-dependent transcriptional transactivation, J. Biol. Chem., 279, 24601, 10.1074/jbc.M402248200 · DOI
- Capell, 1998, The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex, J. Biol. Chem., 273, 3205, 10.1074/jbc.273.6.3205 · DOI
- Capell, 2000, Maturation and pro-peptide cleavage of β-secretase, J. Biol. Chem., 275, 30849, 10.1074/jbc.M003202200 · DOI · Paper page
- Capell, 2005, γ-Secretase complex assembly within the early secretory pathway, J. Biol. Chem., 280, 6471, 10.1074/jbc.M409106200 · DOI
- Chang, 2007, Amyloid-β reduction by memapsin 2 (β-secretase) immunization, FASEB J., 21, 3184, 10.1096/fj.06-7993com · DOI
- Chavez-Gutierrez, 2008, Glu332 in the nicastrin ectodomain Is essential for γ-secretase complex maturation but not for its activity, J. Biol. Chem., 283, 20096, 10.1074/jbc.M803040200 · DOI
- Chen, 2006, TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity, Nature, 440, 1208, 10.1038/nature04667 · DOI
- Chen, 2010, Aph-1 associates directly with full-length and C-terminal fragments of γ-secretase substrates, J. Biol. Chem., 285, 11378, 10.1074/jbc.M109.088815 · DOI
- Cheng, 2009, S-palmitoylation of γ-secretase subunits nicastrin and APH-1, J. Biol. Chem., 284, 1373, 10.1074/jbc.M806380200 · DOI
- Citron, 2010, Alzheimer’s disease: strategies for disease modification, Nat. Rev. Drug Discov., 9, 387, 10.1038/nrd2896 · DOI
- Citron, 1995, Generation of amyloid β protein from its precursor is sequence specific, Neuron, 14, 661, 10.1016/0896-6273(95)90323-2 · DOI
- Creemers, 2001, Processing of β-secretase by furin and other members of the proprotein convertase family, J. Biol. Chem., 276, 4211, 10.1074/jbc.M006947200 · DOI · Paper page
- Crystal, 2003, Membrane topology of γ-secretase component PEN-2, J. Biol. Chem., 278, 20117, 10.1074/jbc.M213107200 · DOI
- De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res., 32, 1808, 10.1093/nar/gkh348 · DOI
- Delarasse, 2011, The purinergic receptor P2X7 triggers α-secretase dependent processing of the amyloid precursor protein, J. Biol. Chem., 286, 2596, 10.1074/jbc.M110.200618 · DOI
- Dries, 2008, Assembly, maturation, and trafficking of the γ-secretase complex in Alzheimer’s disease, Curr. Alzheimer Res., 5, 132, 10.2174/156720508783954695 · DOI
- Dries, 2009, Glu-333 of nicastrin directly participates in γ-secretase activity, J. Biol. Chem., 284, 29714, 10.1074/jbc.M109.038737 · DOI
- Dulin, 2008, P3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers, FEBS Lett., 582, 1865, 10.1016/j.febslet.2008.05.002 · DOI
- Edbauer, 2002, Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation, Proc. Natl Acad. Sci. USA, 99, 8666, 10.1073/pnas.132277899 · DOI
- Edbauer, 2003, Reconstitution of γ-secretase activity, Nat. Cell Biol., 5, 486, 10.1038/ncb960 · DOI
- Edwards, 2008, The ADAM metalloproteinases, Mol. Aspects Med., 29, 258, 10.1016/j.mam.2008.08.001 · DOI
- Esch, 1990, Cleavage of amyloid β peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583 · DOI
- Esler, 2000, Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1, Nat. Cell Biol., 2, 428, 10.1038/35017062 · DOI
- Esler, 2002, Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate, Proc. Natl Acad. Sci. USA, 99, 2720, 10.1073/pnas.052436599 · DOI
- Faca, 2008, Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains, PLoS ONE, 3, 10.1371/journal.pone.0002425 · DOI
- Faghihi, 2008, Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase, Nat. Med., 14, 723, 10.1038/nm1784 · DOI · Paper page
- Farmery, 2003, Partial purification and characterization of γ-secretase from post mortem human brain, J. Biol. Chem., 278, 24277, 10.1074/jbc.M211992200 · DOI
- Fassler, 2010, Masking of transmembrane-based retention signals controls ER export of γ-secretase, Traffic, 11, 250, 10.1111/j.1600-0854.2009.01014.x · DOI
- Ferrando, 2009, The role of NOTCH1 signaling in T-ALL, Hematology Am. Soc. Hematol. Educ. Program, 2009, 353, 10.1182/asheducation-2009.1.353 · DOI
- Fluhrer, 2006, A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b, Nat. Cell Biol., 8, 894, 10.1038/ncb1450 · DOI
- Fluhrer, 2008, Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation, J. Biol. Chem., 283, 30121, 10.1074/jbc.M806092200 · DOI
- Fluhrer, 2009, Intramembrane proteolysis by signal peptide peptidases - a comparative discussion of GxGD-type aspartyl proteases, J. Biol. Chem., 284, 13975, 10.1074/jbc.R800040200 · DOI
- Fortini, 2009, Endocytic regulation of Notch signaling, Curr. Opin. Genet. Dev., 19, 323, 10.1016/j.gde.2009.04.005 · DOI
- Fortna, 2004, Membrane topology and nicastrin-enhanced endoproteolysis of APH-1, a component of the γ-secretase complex, J. Biol. Chem., 279, 3685, 10.1074/jbc.M310505200 · DOI
- Fraering, 2004, Detergent-dependent dissociation of active γ-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex, Biochemistry, 43, 323, 10.1021/bi035748j · DOI
- Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI
- Freeman, 2009, Rhomboids: 7 years of a new protease family, Semin. Cell Dev. Biol., 20, 231, 10.1016/j.semcdb.2008.10.006 · DOI
- Friedmann, 2006, SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production, Nat. Cell Biol., 8, 843, 10.1038/ncb1440 · DOI
- Fukumori, 2010, Three-amino acid spacing of presenilin endoproteolysis suggests a general stepwise cleavage of γ-secretase-mediated intramembrane proteolysis, J. Neurosci., 30, 7853, 10.1523/JNEUROSCI.1443-10.2010 · DOI
- Furukawa, 1996, Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain, J. Neurochem., 67, 1882, 10.1046/j.1471-4159.1996.67051882.x · DOI
- Georgakopoulos, 2006, Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling, EMBO J., 25, 1242, 10.1038/sj.emboj.7601031 · DOI
- Golde, 2009, Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins, Semin. Cell Dev. Biol., 20, 225, 10.1016/j.semcdb.2009.02.003 · DOI
- Gruninger-Leitch, 2002, Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases, J. Biol. Chem., 277, 4687, 10.1074/jbc.M109266200 · DOI · Paper page
- Gu, 2001, Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch, J. Biol. Chem., 276, 35235, 10.1074/jbc.C100357200 · DOI
- Haass, 2004, Take five-BACE and the γ-secretase quartet conduct Alzheimer’s amyloid β-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI
- Haass, 2002, Alzheimer disease γ-secretase: a complex story of GxGD-type presenilin proteases, Trends Cell Biol., 12, 556, 10.1016/S0962-8924(02)02394-2 · DOI
- Hartmann, 2002, The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts, Hum. Mol. Genet., 11, 2615, 10.1093/hmg/11.21.2615 · DOI
- Hayashida, 2010, Molecular and cellular mechanisms of ectodomain shedding, Anat. Rec. (Hoboken), 293, 925, 10.1002/ar.20757 · DOI
- He, 2010, γ-Secretase activating protein is a therapeutic target for Alzheimer’s disease, Nature, 467, 95, 10.1038/nature09325 · DOI
- Hebert, 2004, Coordinated and widespread expression of γ-secretase in vivo: evidence for size and molecular heterogeneity, Neurobiol. Dis., 17, 260, 10.1016/j.nbd.2004.08.002 · DOI
- Hebert, 2006, Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes, EMBO Rep., 7, 739, 10.1038/sj.embor.7400704 · DOI
- Hebert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/β-secretase expression, Proc. Natl Acad. Sci. USA, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
- Heilig, 2010, A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of γ-secretase activity, J. Biol. Chem., 285, 22350, 10.1074/jbc.M110.116962 · DOI
- Hemming, 2008, Proteomic profiling of γ-secretase substrates and mapping of substrate requirements, PLoS Biol., 6, 10.1371/journal.pbio.0060257 · DOI · Paper page
- Henricson, 2005, A novel transmembrane topology of presenilin based on reconciling experimental and computational evidence, FEBS J., 272, 2727, 10.1111/j.1742-4658.2005.04691.x · DOI
- Hitt, 2010, BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization, Mol. Neurodegener., 5, 10.1186/1750-1326-5-31 · DOI · Paper page
- Hong, 2000, Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor, Science (New York, N.Y.), 290, 150, 10.1126/science.290.5489.150 · DOI
- Horiuchi, 2007, Cutting edge: TNF-α-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock, J. Immunol., 179, 2686, 10.4049/jimmunol.179.5.2686 · DOI
- Hu, 2006, Bace1 modulates myelination in the central and peripheral nervous system, Nat. Neurosci., 9, 1520, 10.1038/nn1797 · DOI · Paper page
- Huse, 2000, Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme. The Alzheimer’s disease β-secretase, J. Biol. Chem., 275, 33729, 10.1074/jbc.M004175200 · DOI · Paper page
- Huse, 2002, β-Secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer’s disease brain, J. Biol. Chem., 14
- Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as β-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
- Inoue, 2009, Synaptic activity prompts γ-secretase-mediated cleavage of EphA4 and dendritic spine formation, J. Cell Biol., 185, 551, 10.1083/jcb.200809151 · DOI
- Jacobsen, 1999, The influence of endoproteolytic processing of familial Alzheimer’s disease presenilin 2 on Aβ42 amyloid peptide formation, J. Biol. Chem., 274, 35233, 10.1074/jbc.274.49.35233 · DOI
- Janes, 2005, Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans, Cell, 123, 291, 10.1016/j.cell.2005.08.014 · DOI
- Jorissen, 2010, The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex, J. Neurosci., 30, 4833, 10.1523/JNEUROSCI.5221-09.2010 · DOI · Paper page
- Kaether, 2002, A presenilin-1/nicastrin complex is targeted to the plasma membrane and affects trafficking and processing of the β-amyloid precursor protein, J. Cell Biol., 158, 551, 10.1083/jcb.200201123 · DOI
- Kaether, 2007, Endoplasmic reticulum retention of the γ-secretase complex component Pen2 by Rer1, EMBO Rep., 8, 743, 10.1038/sj.embor.7401027 · DOI
- Kim, 2005, Evidence that the “NF” motif in transmembrane domain 4 of presenilin 1 is critical for binding with PEN-2, J. Biol. Chem., 280, 41953, 10.1074/jbc.M509070200 · DOI
- Kim, 2004, Evidence that assembly of an active γ-secretase complex occurs in the early compartments of the secretory pathway, J. Biol. Chem., 279, 48615, 10.1074/jbc.C400396200 · DOI
- Kimberly, 2000, The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation, J. Biol. Chem., 275, 3173, 10.1074/jbc.275.5.3173 · DOI
- Kimberly, 2003, γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2, Proc. Natl Acad. Sci. USA, 100, 6382, 10.1073/pnas.1037392100 · DOI
- Kitazume, 2002, Characterization of α 2,6-sialyltransferase cleavage by Alzheimer’s β-secretase(BACE1), J. Biol. Chem., 278, 14865, 10.1074/jbc.M206262200 · DOI
- Knappenberger, 2004, Mechanism of γ-secretase cleavage activation: is γ-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?, Biochemistry, 43, 6208, 10.1021/bi036072v · DOI
- Kopan, 2009, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, 137, 216, 10.1016/j.cell.2009.03.045 · DOI
- Kornilova, 2005, The initial substrate-binding site of γ-secretase is located on presenilin near the active site, Proc. Natl Acad. Sci. USA, 102, 3230, 10.1073/pnas.0407640102 · DOI
- Kuhn, 2007, Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase, J. Biol. Chem., 282, 11982, 10.1074/jbc.M700356200 · DOI · Paper page
- Lammich, 1999, Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci., 96, 3922, 10.1073/pnas.96.7.3922 · DOI · Paper page
- Lammich, 2002, Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide, J. Biol. Chem., 277, 44754, 10.1074/jbc.M206872200 · DOI
- Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5’-untranslated region, EMBO Rep., 5, 620, 10.1038/sj.embor.7400166 · DOI
- LaPointe, 2000, The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases, J. Biol. Chem., 275, 1502, 10.1074/jbc.275.2.1502 · DOI
- Laudon, 2005, A nine-transmembrane domain topology for presenilin 1, J. Biol. Chem., 280, 35352, 10.1074/jbc.M507217200 · DOI
- Lazarov, 2006, Electron microscopic structure of purified, active γ-secretase reveals an aqueous intramembrane chamber and two pores, Proc. Natl Acad. Sci. USA, 103, 6889, 10.1073/pnas.0602321103 · DOI
- Le Gall, 2010, ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site, J. Cell Sci., 123, 3913, 10.1242/jcs.069997 · DOI
- Lee, 2002, Mammalian APH-1 interacts with presenilin and nicastrin and Is required for intramembrane proteolysis of amyloid-β precursor protein and Notch, J. Biol. Chem., 277, 45013, 10.1074/jbc.M208164200 · DOI
- Lemberg, 2007, Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases, Genome Res., 17, 1634, 10.1101/gr.6425307 · DOI
- Levitan, 1996, Assessment of normal and mutant human presenilin function in Caenorhabditis elegans, Proc. Natl Acad. Sci. USA, 93, 14940, 10.1073/pnas.93.25.14940 · DOI
- Li, 2004, Cleavage of amyloid-β precursor protein and amyloid-β precursor-like protein by BACE 1, J. Biol. Chem., 279, 10542, 10.1074/jbc.M310001200 · DOI · Paper page
- Li, 2000a, Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state, Proc. Natl Acad. Sci. USA, 97, 6138, 10.1073/pnas.110126897 · DOI
- Li, 2000b, Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 689, 10.1038/35015085 · DOI · Paper page
- Li, 2003, Nicastrin is required for assembly of presenilin/γ-secretase complexes to mediate Notch signaling and for processing and trafficking of β-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003 · DOI
- Lichtenthaler, 2011, α-Secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential, J. Neurochem., 116, 10, 10.1111/j.1471-4159.2010.07081.x · DOI
- Lichtenthaler, 2007, Sheddases and intramembrane-cleaving proteases: RIPpers of the membrane. Symposium on regulated intramembrane proteolysis, EMBO Rep., 8, 537, 10.1038/sj.embor.7400978 · DOI
- Lichtenthaler, 2003, The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1, J. Biol. Chem., 278, 48713, 10.1074/jbc.M303861200 · DOI · Paper page
- Lin, 2000, Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein, Proc. Natl Acad. Sci. USA, 97, 1456, 10.1073/pnas.97.4.1456 · DOI
- Ludwig, 2005, Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules, Comb. Chem. High Throughput Screen, 8, 161, 10.2174/1386207053258488 · DOI
- Martin, 2009, Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis, J. Biol. Chem., 284, 5662, 10.1074/jbc.M807485200 · DOI
- McCarthy, 2009, Presenilin-dependent regulated intramembrane proteolysis and γ-secretase activity, Cell. Mol. Life Sci., 66, 1534, 10.1007/s00018-009-8435-9 · DOI
- Meziane, 1998, Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice, Proc. Natl Acad. Sci. USA, 95, 12683, 10.1073/pnas.95.21.12683 · DOI
- Mitterreiter, 2010, Bepridil and amiodarone simultaneously target the Alzheimer’s disease β- and γ-secretase via distinct mechanisms, J. Neurosci., 30, 8974, 10.1523/JNEUROSCI.1199-10.2010 · DOI
- Moehlmann, 2002, Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production, Proc. Natl Acad. Sci. USA, 99, 8025, 10.1073/pnas.112686799 · DOI
- Morais, 2003, The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the γ-secretase complex, J. Biol. Chem., 278, 43284, 10.1074/jbc.M305685200 · DOI
- Munter, 2007, GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42, EMBO J., 26, 1702, 10.1038/sj.emboj.7601616 · DOI
- Munter, 2010, Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif, J. Biol. Chem., 285, 21636, 10.1074/jbc.M109.088005 · DOI
- Nagano, 2004, Mechanism and biological significance of CD44 cleavage, Cancer Sci., 95, 930, 10.1111/j.1349-7006.2004.tb03179.x · DOI
- Nikolaev, 2009, APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, Nature, 457, 981, 10.1038/nature07767 · DOI · Paper page
- Nyabi, 2003, Presenilins mutated at Asp257 or Asp385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin, J. Biol. Chem., 278, 43430, 10.1074/jbc.M306957200 · DOI
- O’Connor, 2008, Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis, Neuron, 60, 988, 10.1016/j.neuron.2008.10.047 · DOI
- Oh, 2005a, Topology of the C-terminal fragment of human presenilin 1, Biochemistry, 44, 11821, 10.1021/bi0509494 · DOI
- Oh, 2005b, Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space, Am. J. Physiol. Cell Physiol., 289, C576, 10.1152/ajpcell.00636.2004 · DOI
- Okochi, 2002, Presenilins mediate a dual intramembraneous γ-secretase cleavage of Notch-1, EMBO J., 21, 5408, 10.1093/emboj/cdf541 · DOI
- Osenkowski, 2009, Cryoelectron microscopy structure of purified γ-secretase at 12 Å resolution, J. Mol. Biol., 385, 642, 10.1016/j.jmb.2008.10.078 · DOI
- Parkin, 2009, A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10, J. Neurochem., 108, 1464, 10.1111/j.1471-4159.2009.05907.x · DOI
- Perez-Revuelta, 2010, Requirement for small side chain residues within the GxGD-motif of presenilin for γ-secretase substrate cleavage, J. Neurochem., 112, 940, 10.1111/j.1471-4159.2009.06510.x · DOI
- Peschon, 1998, An essential role for ectodomain shedding in mammalian development, Science, 282, 1281, 10.1126/science.282.5392.1281 · DOI
- Podlisny, 1997, Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue, Neurobiol. Dis., 3, 325, 10.1006/nbdi.1997.0129 · DOI
- Postina, 2004, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model, J. Clin. Invest., 113, 1456, 10.1172/JCI20864 · DOI · Paper page
- Qi-Takahara, 2005, Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase, J. Neurosci., 25, 436, 10.1523/JNEUROSCI.1575-04.2005 · DOI · Paper page
- Rajendran, 2008, Efficient inhibition of the Alzheimer’s disease β-secretase by membrane targeting, Science, 320, 520, 10.1126/science.1156609 · DOI
- Reiss, 2009, The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: physiological and cellular functions, Semin. Cell Dev. Biol., 20, 126, 10.1016/j.semcdb.2008.11.002 · DOI
- Ren, 2007, Amyloid β-protein precursor juxtamembrane domain regulates specificity of γ-secretase-dependent cleavages, J. Biol. Chem., 282, 35350, 10.1074/jbc.M702739200 · DOI
- Ring, 2007, The secreted β-amyloid precursor protein ectodomain APPsα is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice, J. Neurosci., 27, 7817, 10.1523/JNEUROSCI.1026-07.2007 · DOI · Paper page
- Rogers, 2004, Differential utilization of upstream AUGs in the β-secretase mRNA suggests that a shunting mechanism regulates translation, Proc. Natl Acad. Sci. USA, 101, 2794, 10.1073/pnas.0308576101 · DOI
- Rossner, 2006, Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer’s disease, Prog. Neurobiol., 79, 95, 10.1016/j.pneurobio.2006.06.001 · DOI
- Sannerud, 2009, Trafficking, a key player in regulated intramembrane proteolysis, Semin. Cell Dev. Biol., 20, 183, 10.1016/j.semcdb.2008.11.004 · DOI
- Sastre, 2001, Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch, EMBO Rep., 2, 835, 10.1093/embo-reports/kve180 · DOI
- Sato, 2006, Structure of the catalytic pore of γ-secretase probed by the accessibility of substituted cysteines, J. Neurosci., 26, 12081, 10.1523/JNEUROSCI.3614-06.2006 · DOI
- Sato, 2007, Active γ-secretase complexes contain only one of each component, J. Biol. Chem., 282, 33985, 10.1074/jbc.M705248200 · DOI
- Sato, 2008a, The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the γ-secretase, J. Neurosci., 28, 6264, 10.1523/JNEUROSCI.1163-08.2008 · DOI
- Sato, 2008b, Distinct pharmacological effects of inhibitors of signal peptide peptidase and γ-secretase, J. Biol. Chem., 283, 33287, 10.1074/jbc.M805670200 · DOI
- Saunders, 1999, BACE maps to chromosome 11 and a BACE homolog, BACE2, reside in the obligate down syndrome region of chromosome 21, Science, 286, 10.1126/science.286.5443.1255a · DOI
- Schmechel, 2004, Human BACE forms dimers and colocalizes with APP, J. Biol. Chem., 279, 39710, 10.1074/jbc.M402785200 · DOI
- Schroeter, 2003, A presenilin dimer at the core of the γ-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis, Proc. Natl Acad. Sci. USA, 100, 13075, 10.1073/pnas.1735338100 · DOI
- Seeger, 1997, Evidence for phosphorylation and oligomeric assembly of presenilin 1, Proc. Natl Acad. Sci. USA, 94, 5090, 10.1073/pnas.94.10.5090 · DOI
- Seiffert, 2000, Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors, J. Biol. Chem., 275, 34086, 10.1074/jbc.M005430200 · DOI
- Selkoe, 2003, Notch and presenilin: regulated intramembrane proteolysis links development and degeneration, Annu. Rev. Neurosci., 26, 565, 10.1146/annurev.neuro.26.041002.131334 · DOI
- Serneels, 2009, γ-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer’s disease, Science, 324, 639, 10.1126/science.1171176 · DOI
- Shah, 2005, Nicastrin functions as a γ-secretase-substrate receptor, Cell, 122, 435, 10.1016/j.cell.2005.05.022 · DOI
- Shimojo, 2008, Enzymatic characteristics of I213T mutant presenilin-1/γ-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs γ-site cleavage of amyloid precursor protein C-terminal fragment β, J. Biol. Chem., 283, 16488, 10.1074/jbc.M801279200 · DOI
- Shirotani, 1997, Determination of a cleavage site of presenilin 2 protein in stably transfected SH-SY5Y human neuroblastoma cell lines, Biochem. Biophys. Res. Commun., 240, 728, 10.1006/bbrc.1997.7730 · DOI
- Shirotani, 2000, Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function, J. Biol. Chem., 275, 3681, 10.1074/jbc.275.5.3681 · DOI
- Shirotani, 2004a, Identification of distinct γ-secretase complexes with different APH-1 variants, J. Biol. Chem., 279, 41340, 10.1074/jbc.M405768200 · DOI
- Shirotani, 2004b, Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin - identification of nicastrin mutants which selectively interact with APH-1, J. Neurochem., 89, 1520, 10.1111/j.1471-4159.2004.02447.x · DOI
- Shirotani, 2007, Pathological activity of familial Alzheimer’s disease-associated mutant presenilin can be executed by six different γ-secretase complexes, Neurobiol. Dis., 27, 102, 10.1016/j.nbd.2007.04.011 · DOI
- Sinha, 1999, Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
- Sisodia, 1992, β-Amyloid precursor protein cleavage by a membrane-bound protease, Proc. Natl Acad. Sci. USA, 89, 6075, 10.1073/pnas.89.13.6075 · DOI
- Skovronsky, 2000, Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-golgi network, J. Biol. Chem., 275, 2568, 10.1074/jbc.275.4.2568 · DOI
- Sobhanifar, 2010, Structural investigation of the C-terminal catalytic fragment of presenilin 1, Proc. Natl Acad. Sci. USA, 107, 9644, 10.1073/pnas.1000778107 · DOI
- Solans, 2000, A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer’s amyloid precursor protein β-secretase, Cytogenet. Cell Genet., 89, 177, 10.1159/000015608 · DOI
- Song, 1999, Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations, Proc. Natl Acad. Sci. USA, 96, 6959, 10.1073/pnas.96.12.6959 · DOI · Paper page
- Spasic, 2008, Building γ-secretase: the bits and pieces, J. Cell Sci., 121, 413, 10.1242/jcs.015255 · DOI
- Spasic, 2006, Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway, J. Biol. Chem., 281, 26569, 10.1074/jbc.M600592200 · DOI
- Spasic, 2007, Rer1p competes with APH-1 for binding to nicastrin and regulates γ-secretase complex assembly in the early secretory pathway, J. Cell Biol., 176, 629, 10.1083/jcb.200609180 · DOI
- Steiner, 1998, The proprotein convertases, Curr. Opin. Chem. Biol., 2, 31, 10.1016/S1367-5931(98)80033-1 · DOI
- Steiner, 1999a, Amyloidogenic function of the Alzheimer’s disease-associated presenilin 1 in the absence of endoproteolysis, Biochemistry, 38, 14600, 10.1021/bi9914210 · DOI
- Steiner, 1999b, A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling, J. Biol. Chem., 274, 28669, 10.1074/jbc.274.40.28669 · DOI
- Steiner, 2000, Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases, Nat. Cell Biol., 2, 848, 10.1038/35041097 · DOI
- Steiner, 2002, PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin, J. Biol. Chem., 277, 39062, 10.1074/jbc.C200469200 · DOI
- Steiner, 2008, Chemical cross-linking provides a model of the γ-secretase complex subunit architecture and evidence for close proximity of the C-terminal fragment of presenilin with APH-1, J. Biol. Chem., 283, 34677, 10.1074/jbc.M709067200 · DOI
- Struhl, 2000, Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins, Mol. Cell, 6, 625, 10.1016/S1097-2765(00)00061-7 · DOI
- Takagi, 2010, Participation of transmembrane domain 1 of presenilin 1 in the catalytic pore structure of the γ-secretase, J. Neurosci., 30, 15943, 10.1523/JNEUROSCI.3318-10.2010 · DOI
- Takami, 2009, γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment, J. Neurosci., 29, 13042, 10.1523/JNEUROSCI.2362-09.2009 · DOI · Paper page
- Takasugi, 2003, The role of presenilin cofactors in the γ-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI
- van Tetering, 2009, Metalloprotease ADAM10 is required for Notch1 site 2 cleavage, J. Biol. Chem., 284, 31018, 10.1074/jbc.M109.006775 · DOI
- Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 · DOI
- Thinakaran, 1998, Stable association of presenilin derivatives and absence of presenilin interactions with APP, Neurobiol. Dis., 4, 438, 10.1006/nbdi.1998.0171 · DOI
- Tolia, 2006, Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the γ-secretase complex, J. Biol. Chem., 281, 27633, 10.1074/jbc.M604997200 · DOI
- Tolia, 2008, Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of γ-secretase, J. Biol. Chem., 283, 19793, 10.1074/jbc.M802461200 · DOI
- Tomita, 2009, Secretase inhibitors and modulators for Alzheimer’s disease treatment, Expert Rev. Neurother., 9, 661, 10.1586/ern.09.24 · DOI
- Tousseyn, 2009, ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase, J. Biol. Chem., 284, 11738, 10.1074/jbc.M805894200 · DOI
- Vassar, 2009, The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential, J. Neurosci., 29, 12787, 10.1523/JNEUROSCI.3657-09.2009 · DOI · Paper page
- Wakabayashi, 2009, Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomains, Nat. Cell Biol., 11, 1340, 10.1038/ncb1978 · DOI · Paper page
- Wang, 2006a, C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation, J. Neurochem., 96, 218, 10.1111/j.1471-4159.2005.03548.x · DOI
- Wang, 2006b, Crystal structure of a rhomboid family intramembrane protease, Nature, 444, 179, 10.1038/nature05255 · DOI
- Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1, J. Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
- Watanabe, 2005, Pen-2 is incorporated into the γ-secretase complex through binding to transmembrane domain 4 of presenilin 1, J. Biol. Chem., 280, 41967, 10.1074/jbc.M509066200 · DOI
- Weidemann, 2002, A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing, Biochemistry, 41, 2825, 10.1021/bi015794o · DOI
- Weihofen, 2002, Identification of signal peptide peptidase, a presenilin-type aspartic protease, Science, 296, 2215, 10.1126/science.1070925 · DOI
- Westmeyer, 2004, Dimerization of β-site β-amyloid precursor protein-cleaving enzyme, J. Biol. Chem., 279, 53205, 10.1074/jbc.M410378200 · DOI
- Willem, 2009, Function, regulation and therapeutic properties of β-secretase (BACE1), Semin. Cell Dev. Biol., 20, 175, 10.1016/j.semcdb.2009.01.003 · DOI
- Willems, 2010, Thiol isomerases negatively regulate the cellular shedding activity of ADAM17, Biochem. J., 428, 439, 10.1042/BJ20100179 · DOI
- Winkler, 2009, Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human γ-secretase, Biochemistry, 48, 1183, 10.1021/bi801204g · DOI
- Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity, Nature, 398, 513, 10.1038/19077 · DOI
- Wong, 2005, β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase, J. Biol. Chem., 280, 23009, 10.1074/jbc.M414648200 · DOI
- Wu, 2006, Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry, Nat. Struct. Mol. Biol., 13, 1084, 10.1038/nsmb1179 · DOI
- Xu, 2010, Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation, Mol. Cell, 37, 551, 10.1016/j.molcel.2010.01.034 · DOI
- Yamasaki, 2006, The GxGD motif of presenilin contributes to catalytic function and substrate identification of γ-secretase, J. Neurosci., 26, 3821, 10.1523/JNEUROSCI.5354-05.2006 · DOI
- Yan, 1999, Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity, Nature, 402, 533, 10.1038/990107 · DOI · Paper page
- Yanagida, 2009, The 28-amino acid form of an APLP1-derived Aβ-like peptide is a surrogate marker for Aβ42 production in the central nervous system, EMBO Mol. Med., 1, 223, 10.1002/emmm.200900026 · DOI
- Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470 · DOI
200 of 206 shown
Cited by
Sorted by citations
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Self-citationTREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798
Self-citationNot just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus
Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., et al. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917095514 · Cited by 236
Making the final cut: Pathogenic amyloid-β peptide generation by γ-secretase
Steiner, H., Fukumori, A., Tagami, S., & Okochi, M. (2018) · Cell Stress · doi:10.15698/cst2018.11.162 · Cited by 133
Self-citationPigoni, M., Wanngren, J., Kuhn, P.-H., Munro, K. M., Gunnersen, J. M., Takeshima, H., Feederle, R., Voytyuk, I., De Strooper, B., Levasseur, M. D., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0134-z · Cited by 125
Self-citationAvila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
Greenough, M. A., Lane, D. J. R., Balez, R., Anastacio, H. T. D., Zeng, Z., Ganio, K., McDevitt, C. A., Acevedo, K., Belaidi, A. A., Koistinaho, J., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-01003-1 · Cited by 102
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63
Liquid-liquid phase separation in Alzheimer’s disease
Fu, Q., Zhang, B., Chen, X., & Chu, L. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02407-3 · Cited by 33
Aβ43 levels determine the onset of pathological amyloid deposition
Tambini, M. D., Yin, T., Yesiltepe, M., Breuillaud, L., Zehntner, S. P., d'Abramo, C., Giliberto, L., & D'Adamio, L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104868 · Cited by 8
Covalent fragment inhibits intramembrane proteolysis
Eden, A., Zhao, J., Xiao, Y., Gibson, J., & Wang, C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.958399 · Cited by 3
Metadata
- Authors
- Lichtenthaler, S. F., Haass, C., & Steiner, H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-04-14
- Volume
- 117
- Issue
- 5
- Pages
- 779-796
- ISSN
- 0022-3042
- Cited by
- 205
- References
- 13
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review